Antiviral antibodies inhibit the lysis of tumour cells by anti-H–2 sera


RECENT experiments have indicated that the cytolysis of virus-infected, chemically modified, or neoplastic cells by murine T lymphocytes is restricted to target cells carrying one or more of the H–2 antigens possessed by the cells against which the cytotoxic T cells were generated1–10. Two general hypotheses have been proposed to explain the participation of H–2 antigens in T–cell-mediated cytolysis. According to one hypothesis, T lymphocytes possess two different types of receptors, one which recognises the abnormal antigens of the target cell, and a second which interacts with the H–2 antigens of that cell. In the alternative hypothesis, the T cell has only one specific receptor that is directed against a complex antigenic determinant made of of H–2 antigens and viral antigens, for example, tumour antigens induced by viral infection. Neither of these hypotheses has yet been satisfactorily proven. In support of the one-receptor hypothesis, we have found that anti-H–2 and antiviral sera show copatching and cocapping of H–2 and viral antigens on the surface of EL4 leukaemia cells9, suggesting that viral and H–2 antigenic determinants can be in close physical association on the cell surface. Here we provide new evidence for the existence of a close association between H–2 antigens and viral antigens on murine leukaemia cells.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Doherty, P. C., Blanden, R. V., and Zinkernagel, R. M., Transplant. Rev., 29, 89–124 (1976).

  2. 2

    Schrader, J. W., Henning, R., Milner, R. J., and Edelman, G. M., in XLI Cold Spring Harb. Symp. quant. Biol. (in the press).

  3. 3

    Shearer, G. M., Rehn, T. G., and Garbarino, C. A., J. exp. Med., 141, 1348–1346 (1975).

  4. 4

    Gomard, E., Duprez, V., Henin, Y., and Levy, J. P., Nature, 260, 707–709 (1976).

  5. 5

    Pfizenmaier, K., Starzinksi-Powitz, A., Rodt, H., Röllinghoff, M., and Wagner, H., J. exp. Med., 143, 999–1004 (1976).

  6. 6

    Zinkernagel, R. M., Nature, 261, 139–141 (1976).

  7. 7

    v. Boehmer, H., and Haas, W., Nature, 261, 141–142 (1976).

  8. 8

    Germain, R. N., Dorf, M. E., and Benecerref, B., J. exp. Med., 142, 1023–1028 (1975).

  9. 9

    Schrader, J. W., Cunningham, B. A., and Edelman, G. M., Proc. natn. Acad. Sci. U.S.A., 72, 5066–5070 (1975).

  10. 10

    Schrader, J. W., and Edelman, G. M., J. exp. Med., 143, 601–614 (1976).

  11. 11

    Bernoco, D., Cullen, S., Scudeller, G., Trinchieri, G., and Ceppellini, R., in Histocompatibility Testing (edit. by Dausset, J., and Colombani, J.), 527–537 (Munksgaard, Copenhagen, 1973).

  12. 12

    Hauptfeld, V., Hauptfeld, M., and Klein, J., J. exp. Med., 141, 1047–1056 (1975).

  13. 13

    Milner, R. J., Henning, R., and Edelman, G. M., Eur. J. Immun. (in the press).

  14. 14

    Klein, P. A., J. Immun., 115, 1254–1260 (1975).

  15. 15

    Nowinski, R. C., and Klein, P. A., J. Immun., 115, 1261–1268 (1975).

  16. 16

    Blanden, R. V., Hapel, A. J., and Jackson, D. C., Immunocheinistry, 13, 179–191 (1976).

  17. 17

    Bevan, M. J., Nature, 256, 419–421 (1975).

  18. 18

    Gordon, R. D., Simpson, E., and Samelson, L. E., J. exp. Med., 142, 1108–1120 (1975).

  19. 19

    Henning, R., Milner, R. J., Reske, K., Cunningham, B. A., and Edelman, G. M., Proc. natn. Acad. Sci. U.S.A., 73, 188–122 (1976).

  20. 20

    Boyum, A., Scand. J. clin. lab. Invest., 21, 1–109 (1968).

  21. 21

    Mãrchalonis, J. J., and Cone, R. E., Santer, V., Biochem. J., 124, 921–927 (1971).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

HENNING, R., SCHRADER, J. & EDELMAN, G. Antiviral antibodies inhibit the lysis of tumour cells by anti-H–2 sera. Nature 263, 689–691 (1976) doi:10.1038/263689a0

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.